Filters close
Newswise: First Patient Receives ACES™ Automatic Continuous Effusion Shunt System at UNC School of Medicine for Pleural Effusion
Release date: 2-Jul-2024 2:05 PM EDT
First Patient Receives ACES™ Automatic Continuous Effusion Shunt System at UNC School of Medicine for Pleural Effusion
University of North Carolina School of Medicine

In collaboration with the company Pleural Dynamics, researchers at the UNC School of Medicine are the first to use a fully implantable automatic effusion shunt with no external catheters or expensive drainage canisters to provide an innovative new option for patients who struggle with chronic fluid collection.

UNREVIEWED

Newswise: UNC Health Researchers Present Preliminary Data on Weight Loss Drugs on Alcohol Addiction
Released: 27-Jun-2024 1:05 PM EDT
UNC Health Researchers Present Preliminary Data on Weight Loss Drugs on Alcohol Addiction
University of North Carolina School of Medicine

Christian Hendershot, PhD, associate professor of psychiatry and director of the Clinical and Translational Addiction Research Program at the UNC School of Medicine, presented early findings from the first completed randomized controlled trial of semaglutide for reducing alcohol consumption in heavy drinkers.

Released: 27-Jun-2024 12:05 PM EDT
Inaugural “North Carolina Men’s Health Report Card” Provides a Snapshot of the Most Pressing Issues Affecting Men Throughout the State
University of North Carolina School of Medicine

June is National Men’s Health Month: The report serves as a call to action for local and state organizations as well as the public, to seek important changes that can have far-reaching, positive impacts on the health of North Carolinians.

Newswise: New Study Suggests Higher Amounts of Intervention May Not Be More Helpful for Children on the Autism Spectrum
Released: 25-Jun-2024 10:05 AM EDT
New Study Suggests Higher Amounts of Intervention May Not Be More Helpful for Children on the Autism Spectrum
University of North Carolina School of Medicine

After a thorough systematic analysis, researchers at the UNC School of Medicine and other institutions found that evidence was lacking that higher intensity interventions provided increased benefits for young autistic children.

Newswise: Do Institutions Support Partner Hiring? A New Tool Ranks Universities
Released: 24-Jun-2024 9:05 AM EDT
Do Institutions Support Partner Hiring? A New Tool Ranks Universities
University of North Carolina School of Medicine

To raise awareness and assist couples with job searches, UNC-Chapel Hill researchers launched an evidence-based tool showing how research-intensive institutions rank in partner hiring – providing insights on where they may be excelling and where they may be deficient. Jill Fisher, PhD, professor of social medicine at the UNC School of Medicine, co-led the project.

Newswise: Researchers Wrestle with Accuracy of AI Technology Used to Create New Drug Candidates
12-May-2024 8:00 PM EDT
Researchers Wrestle with Accuracy of AI Technology Used to Create New Drug Candidates
University of North Carolina School of Medicine

Researchers at the UNC School of Medicine, UCSF, Stanford, and Harvard determined that a protein prediction technology can yield accurate results in the hunt to efficiently find the best possible drug candidates for many conditions.

   
Newswise: Scientists Discover Surprising Details about Xylazine in Combination with Fentanyl
Released: 14-May-2024 7:00 AM EDT
Scientists Discover Surprising Details about Xylazine in Combination with Fentanyl
University of North Carolina School of Medicine

Xylazine, often found in street-drug combo with fentanyl, was thought to only bind to the α2-adrenergic receptor, but UNC-Chapel Hill scientists discovered it also binds to opioid receptors, which could have profound impacts on fentanyl overdose treatment.

Newswise: Researchers Engineer Yeast to Transport Medicines and Lower Inflammation for Potential Treatment of Inflammatory Bowel Disease
Released: 7-May-2024 9:05 AM EDT
Researchers Engineer Yeast to Transport Medicines and Lower Inflammation for Potential Treatment of Inflammatory Bowel Disease
University of North Carolina School of Medicine

Researchers at the UNC Eshelman School of Pharmacy and the UNC School of Medicine have engineered a probiotic yeast that enhances probiotic absorption in the gut and has the ability to suppress and even reverse inflammation in animals.

Newswise: Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients
Released: 24-Apr-2024 3:05 PM EDT
Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients
University of North Carolina School of Medicine

Colonoscopy is often recommended following an episode of diverticulitis to exclude missed colorectal cancer (CRC). Now one study, published in the Clinical Gastroenterology and Hepatology journal, shows that the prevalence of CRC is low in most patients with diverticulitis. However, patients with complicated diverticulitis are the exception.

Newswise: Researchers Now Know Precisely How We Perceive Bitter Taste
Released: 11-Apr-2024 10:05 AM EDT
Researchers Now Know Precisely How We Perceive Bitter Taste
University of North Carolina School of Medicine

A new study led by researchers at the UNC School of Medicine unravels the structure of TAS2R14, a taste receptor that allows us to taste bitter substances. In addition to solving the protein structure, the findings could help scientists develop drugs that targeting taste receptors.

Newswise: Researchers Demonstrate How Vital Conditions Enable Perinatal Well-Being
Released: 2-Apr-2024 3:05 PM EDT
Researchers Demonstrate How Vital Conditions Enable Perinatal Well-Being
University of North Carolina Health Care System

Perinatal mental illness is a leading cause of death during pregnancy and the first postpartum year in the U.S. Alison Stuebe, MD, MSc, professor of maternal fetal medicine in the Department of Obstetrics and Gynecology at the UNC School of Medicine, authored a study with colleagues on how a holistic approach comprising seven domains can foster conditions for women and birthing people to thrive.

Newswise: International Graduate and Postdoctoral Trainees in Biomedicine Are Struggling with Career Confidence, Study Says
Released: 21-Mar-2024 12:05 PM EDT
International Graduate and Postdoctoral Trainees in Biomedicine Are Struggling with Career Confidence, Study Says
University of North Carolina School of Medicine

A new study, led by researchers at the UNC School of Medicine and collaborators from the NIH Broadening Experiences in Scientific Training (NIH BEST) consortium, examined career confidence in graduate and postdoctoral trainees and explored how to better support international trainees across a diverse array of career paths.

Newswise: A New Study Shows How Neurochemicals Affect fMRI Readings
Released: 18-Mar-2024 4:05 PM EDT
A New Study Shows How Neurochemicals Affect fMRI Readings
University of North Carolina School of Medicine

A landmark study, led by Yen-Yu Ian Shih, PhD, at the UNC School of Medicine, shows how neurochemicals can influence blood vessels. The new findings may alter how researchers interpret results from functional magnetic resonance imaging.

Newswise: We Now Know Why Killer T Cells Lose Energy Inside of Solid Tumors
Released: 15-Mar-2024 11:05 AM EDT
We Now Know Why Killer T Cells Lose Energy Inside of Solid Tumors
University of North Carolina School of Medicine

Researchers at the UNC School of Medicine have found that a metabolic enzyme called Acetyl-CoA Carboxylase causes T cells to store fat when they are in solid tumors, rather than burning fat for energy.

Released: 12-Mar-2024 10:30 AM EDT
Researchers Expand Our Understanding of How the Body and Brain Communicate
University of North Carolina School of Medicine

Researchers investigating how exactly the brain processes the incoming stream of information from the heart and lungs, discovered that specific neurons in the thalamus are actively involved in processing cardiac and respiratory signals.

Newswise: Hahn Awarded CZI Grant to Monitor, Manipulate Proteins Important in Nervous System Function, Neurological Disease
Released: 29-Feb-2024 11:00 AM EST
Hahn Awarded CZI Grant to Monitor, Manipulate Proteins Important in Nervous System Function, Neurological Disease
University of North Carolina School of Medicine

Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.

Released: 28-Feb-2024 3:05 PM EST
How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis
University of North Carolina School of Medicine

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

Newswise: Research Shows Continued Cocaine Use Disrupts Communication Between Major Brain Networks
Released: 28-Feb-2024 1:05 PM EST
Research Shows Continued Cocaine Use Disrupts Communication Between Major Brain Networks
University of North Carolina School of Medicine

New research at the UNC School of Medicine provides new insights into the brain processes that underlie cocaine addiction. The findings are crucial for developing new therapeutics and identifying an imaging marker for cocaine use disorders.

Newswise: Berkowitz Authors NEJM Perspective Piece on Food Insecurity
Released: 26-Feb-2024 2:05 PM EST
Berkowitz Authors NEJM Perspective Piece on Food Insecurity
University of North Carolina Health Care System

Published in the New England Journal of Medicine, Seth A. Berkowitz, MD, MPH, associate professor of medicine at the UNC School of Medicine, wrote perspective piece on how medically tailored meals address health consequences of food insecurity.

Newswise: Drug in OUtMATCH Clinical Trial FDA-Approved for the Reduction of Allergic Reactions from Accidental Food Exposures
Released: 26-Feb-2024 11:05 AM EST
Drug in OUtMATCH Clinical Trial FDA-Approved for the Reduction of Allergic Reactions from Accidental Food Exposures
University of North Carolina Health Care System

Stage one results from the OUtMATCH clinical trial, published in the New England Journal of Medicine, show that a monoclonal antibody, omalizumab, increased the amount of peanut, tree nuts, egg, milk and wheat that multi-food allergic children as young as age one could consume without an allergic reaction. Edwin Kim, MD, Corinne Keet, MD, PhD, and Mike Kulis, PhD, are contributing authors.



close
0.14662